Peter M. Silberfarb

3.5k total citations
46 papers, 2.8k citations indexed

About

Peter M. Silberfarb is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Psychiatry and Mental health. According to data from OpenAlex, Peter M. Silberfarb has authored 46 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 11 papers in Psychiatry and Mental health. Recurrent topics in Peter M. Silberfarb's work include Cancer-related cognitive impairment studies (11 papers), Cancer survivorship and care (8 papers) and Childhood Cancer Survivors' Quality of Life (7 papers). Peter M. Silberfarb is often cited by papers focused on Cancer-related cognitive impairment studies (11 papers), Cancer survivorship and care (8 papers) and Childhood Cancer Survivors' Quality of Life (7 papers). Peter M. Silberfarb collaborates with scholars based in United States and United Kingdom. Peter M. Silberfarb's co-authors include L. Herbert Maurer, Peter M. Levine, Z. J. Lipowski, Tim A. Ahles, David Cella, E. John Orav, Jimmie C. Holland, Marie Bakitas Whedon, Thomas E. Oxman and Bernard F. Cole and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and American Journal of Psychiatry.

In The Last Decade

Peter M. Silberfarb

43 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter M. Silberfarb United States 26 1.1k 892 636 433 409 46 2.8k
Michael A. Weitzner United States 27 1.4k 1.3× 1.0k 1.2× 887 1.4× 694 1.6× 1.1k 2.6× 44 3.5k
Richard Heinrich United States 25 1.3k 1.2× 439 0.5× 666 1.0× 139 0.3× 644 1.6× 60 3.2k
Diane Von Ah United States 29 1.1k 1.1× 1.2k 1.4× 449 0.7× 482 1.1× 291 0.7× 109 2.7k
Valerie Shilling United Kingdom 25 386 0.4× 1.1k 1.2× 487 0.8× 627 1.4× 389 1.0× 55 2.4k
Marieke Gielissen Netherlands 30 2.3k 2.2× 1.3k 1.5× 1.2k 2.0× 122 0.3× 289 0.7× 62 3.5k
R Schwarz Germany 25 1.2k 1.1× 484 0.5× 542 0.9× 35 0.1× 342 0.8× 109 2.7k
Marilyn Hockenberry United States 31 541 0.5× 449 0.5× 2.5k 3.9× 164 0.4× 931 2.3× 135 3.5k
Vida L. Tyc United States 29 224 0.2× 301 0.3× 1.4k 2.1× 264 0.6× 579 1.4× 81 2.4k
Fannie Gaston‐Johansson United States 34 1.4k 1.3× 554 0.6× 918 1.4× 30 0.1× 602 1.5× 65 3.1k
C.A.H.H.V.M. Verhagen Netherlands 21 1.1k 1.0× 630 0.7× 642 1.0× 60 0.1× 238 0.6× 42 1.7k

Countries citing papers authored by Peter M. Silberfarb

Since Specialization
Citations

This map shows the geographic impact of Peter M. Silberfarb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter M. Silberfarb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter M. Silberfarb more than expected).

Fields of papers citing papers by Peter M. Silberfarb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter M. Silberfarb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter M. Silberfarb. The network helps show where Peter M. Silberfarb may publish in the future.

Co-authorship network of co-authors of Peter M. Silberfarb

This figure shows the co-authorship network connecting the top 25 collaborators of Peter M. Silberfarb. A scholar is included among the top collaborators of Peter M. Silberfarb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter M. Silberfarb. Peter M. Silberfarb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Silberfarb, Peter M. & Thomas E. Oxman. (2015). The Effects of Cancer Therapies on the Central Nervous System. Advances in psychosomatic medicine. 18. 13–25. 1 indexed citations
2.
Ahles, Tim A., Denise M. Tope, Susan E. Walch, et al.. (1999). Massage Therapy for Patients Undergoing Autologous Bone Marrow Transplantation. Journal of Pain and Symptom Management. 18(3). 157–163. 138 indexed citations
3.
Ahles, Tim A., Peter M. Silberfarb, James E. Herndon, et al.. (1998). Psychologic and neuropsychologic functioning of patients with limited small-cell lung cancer treated with chemotherapy and radiation therapy with or without warfarin: a study by the Cancer and Leukemia Group B.. Journal of Clinical Oncology. 16(5). 1954–1960. 85 indexed citations
4.
Ahles, Tim A., et al.. (1998). Knowledge and Attitudes of Health-Care Providers Toward Cancer Pain Management. Journal of Pain and Symptom Management. 15(6). 335–349. 93 indexed citations
5.
Ahles, Tim A., Peter M. Silberfarb, Amy Chen Rundle, et al.. (1994). Quality of Life in Patients with Limited Small-Cell Carcinoma of the Lung Receiving Chemotherapy with or without Radiation Therapy, for Cancer and Leukemia Group B. Psychotherapy and Psychosomatics. 62(3-4). 193–199. 16 indexed citations
6.
Tope, Denise M., Tim A. Ahles, & Peter M. Silberfarb. (1993). Psycho-Oncology: Psychological Well·Being as One Component of Quality of Life. Psychotherapy and Psychosomatics. 60(3-4). 129–147. 28 indexed citations
7.
Cella, David, E. John Orav, Alice B. Kornblith, et al.. (1991). Socioeconomic status and cancer survival.. Journal of Clinical Oncology. 9(8). 1500–1509. 184 indexed citations
8.
Redd, William H., Peter M. Silberfarb, Barbara L. Andersen, et al.. (1991). Physiologic and psychobehavioral research in oncology. Cancer. 67(S3). 813–822. 51 indexed citations
9.
Silberfarb, Peter M., et al.. (1991). Mood and clinical status in patients with multiple myeloma.. Journal of Clinical Oncology. 9(12). 2219–2224. 35 indexed citations
10.
Silberfarb, Peter M.. (1988). Psychiatric Treatment Of the Patient during Cancer Therapy. CA A Cancer Journal for Clinicians. 38(3). 133–137. 6 indexed citations
11.
Cella, David, Jimmie C. Holland, Peter M. Silberfarb, et al.. (1987). The relationship of psychological distress, extent of disease, and performance status in patients with lung cancer. Cancer. 60(7). 1661–1667. 120 indexed citations
12.
Cella, David, Paul B. Jacobsen, E. John Orav, et al.. (1987). A brief poms measure of distress for cancer patients. Journal of Chronic Diseases. 40(10). 939–942. 170 indexed citations
13.
Choi, Noah C., et al.. (1987). Accelerated radiotherapy followed by chemotherapy for locally recurrent small-cell carcinoma of the lung. A phase II study of cancer and leukemia group B. International Journal of Radiation Oncology*Biology*Physics. 13(2). 263–266. 11 indexed citations
14.
Silberfarb, Peter M.. (1984). Response. Cancer. 53(S10). 2255–2257. 1 indexed citations
15.
Silberfarb, Peter M.. (1984). Psychiatric problems in breast cancer. Cancer. 53(S3). 820–824. 32 indexed citations
16.
Silberfarb, Peter M.. (1982). Research in adaptation to illness and psychosocial intervention an overview. Cancer. 50(S9). 1921–1925. 7 indexed citations
17.
Silberfarb, Peter M. & Peter M. Levine. (1980). Psychosocial aspects of neoplastic disease. General Hospital Psychiatry. 2(3). 192–197. 68 indexed citations
18.
Silberfarb, Peter M.. (1978). Psychiatric Themes in the Rehabilitation of Mastectomy Patients. The International Journal of Psychiatry in Medicine. 8(2). 159–167. 10 indexed citations
19.
Tucker, G, Edward W. Campion, & Peter M. Silberfarb. (1975). Sensorimotor functions and cognitive disturbance in psychiatric patients. American Journal of Psychiatry. 132(1). 17–21. 81 indexed citations
20.
Sarosi, George A., et al.. (1971). Aspergillomas occurring in blastomycotic cavities.. PubMed. 104(4). 581–4. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael A. Weitzner Breakdown of academic impact, for papers by Richard Heinrich Breakdown of academic impact, for papers by Diane Von Ah Breakdown of academic impact, for papers by Valerie Shilling Breakdown of academic impact, for papers by Marieke Gielissen Breakdown of academic impact, for papers by R Schwarz Breakdown of academic impact, for papers by Marilyn Hockenberry Breakdown of academic impact, for papers by Vida L. Tyc Breakdown of academic impact, for papers by Fannie Gaston‐Johansson Breakdown of academic impact, for papers by C.A.H.H.V.M. Verhagen
Rankless by CCL
2026